We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$22.3B
AUM Growth
+$4.85B
(+28%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
18.06%
Top 10 Holdings %
Top 10 Hldgs %
53.96%
Holding
76
New
19
Increased
16
Reduced
22
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$1.7B |
| 2 |
Boeing
BA
|
+$1.01B |
| 3 |
Amazon
AMZN
|
+$915M |
| 4 |
Meta Platforms (Facebook)
META
|
+$902M |
| 5 |
BridgeBio Pharma
BBIO
|
+$726M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$889M |
| 2 |
Marathon Petroleum
MPC
|
+$823M |
| 3 |
Visa
V
|
+$440M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$314M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.43% |
| 2 | Technology | 16.88% |
| 3 | Consumer Discretionary | 15.43% |
| 4 | Communication Services | 13.36% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$12.4B
| $222M | 1% |
2,590,351
-2,538,558
| -49% | -$217M |
|
27
Avantor
AVTR
$9.19B
| $217M | 0.97% |
+11,345,684
| New | +$202M |
|
|
XYZ
28
Block Inc
XYZ
$47.5B
| $193M | 0.86% |
+2,657,236
| New | +$186M |
|
29
Equitable Holdings
EQH
$14.1B
| $185M | 0.83% |
8,842,350
+8,160,750
| +1,197% | +$176M |
|
|
WORK
30
DELISTED
Slack Technologies, Inc.
WORK
| $170M | 0.76% |
+4,539,615
| New | +$167M |
|
31
Aon
AON
$76B
| $164M | 0.74% |
851,778
+197,554
| +30% | +$35.8M |
|
32
DaVita
DVA
$11.7B
| $164M | 0.73% |
2,907,034
+151,529
| +5% | +$7.85M |
|
33
Crown Holdings
CCK
$13.1B
| $140M | 0.63% |
2,293,475
+267,576
| +13% | +$15.6M |
|
34
Lowe's Companies
LOW
$125B
| $139M | 0.63% |
+1,381,012
| New | +$146M |
|
35
NVIDIA
NVDA
$5.42T
| $132M | 0.59% |
32,093,200
-43,320,160
| -57% | -$180M |
|
|
COUP
36
DELISTED
Coupa Software Incorporated
COUP
| $126M | 0.57% |
+997,832
| New | +$107M |
|
37
Alphabet (Google) Class C
GOOG
$4.32T
| $123M | 0.55% |
2,283,440
-469,400
| -17% | -$27.1M |
|
38
Moderna
MRNA
$23.6B
| $120M | 0.54% |
8,197,458
-8,470,408
| -51% | -$182M |
|
39
A.O. Smith
AOS
$8.7B
| $116M | 0.52% |
+2,452,092
| New | +$120M |
|
|
WCG
40
DELISTED
Wellcare Health Plans, Inc.
WCG
| $106M | 0.48% |
371,450
-948,954
| -72% | -$262M |
|
|
41
Alibaba
BABA
$308B
| $99.5M | 0.45% |
587,268
-5,149,456
| -90% | -$889M |
|
|
GRUB
42
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $99M | 0.44% |
+634,593
| New | +$86.5M |
|
|
BERY
43
DELISTED
Berry Global Group, Inc.
BERY
| $94.9M | 0.43% |
1,965,446
-6,443,465
| -77% | -$310M |
|
|
SYNH
44
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $91.8M | 0.41% |
1,796,775
-422,299
| -19% | -$19.7M |
|
|
CTLT
45
DELISTED
CATALENT, INC.
CTLT
| $86.5M | 0.39% |
1,595,579
+535,066
| +50% | +$24.5M |
|
|
CVET
46
DELISTED
Covetrus, Inc. Common Stock
CVET
| $82.7M | 0.37% |
3,381,937
-508,000
| -13% | -$14.6M |
|
|
RTN
47
DELISTED
Raytheon Company
RTN
| $78.3M | 0.35% |
+450,432
| New | +$81M |
|
|
48
Visa
V
$677B
| $67.2M | 0.3% |
387,368
-2,687,425
| -87% | -$440M |
|
|
ATH
49
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $66.9M | 0.3% |
+1,554,576
| New | +$67.2M |
|
50
NXP Semiconductors
NXPI
$60.4B
| $65.4M | 0.29% |
670,065
-2,055,324
| -75% | -$199M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Viking Global Investors held 76 positions worth $22.3B, up 28% from $17.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Viking Global Investors deployed $4.03B of net new capital in Q2 2019, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $889M trimmed.
- Viking Global Investors's largest Q2 2019 buy was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
- Viking Global Investors added most to Amazon in Q2 2019, an estimated $915M increase.
- Viking Global Investors's biggest Q2 2019 reduction was Alibaba, cutting an estimated $889M.
- Viking Global Investors fully exited Marathon Petroleum in Q2 2019, selling an estimated $823M.
- Viking Global Investors's ten largest holdings make up 54% of its $22.3B portfolio in Q2 2019.
- Viking Global Investors opened 19 new positions and closed 17 in Q2 2019.
- Viking Global Investors's portfolio value rose 28% quarter-over-quarter to $22.3B.
Based on Viking Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.